238. Vitamin D-resistant rickets Clinical trials / Disease details
Clinical trials : 29 / Drugs : 25 - (DrugBank : 11) / Drug target genes : 4 - Drug target pathways : 20
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00473187 (ClinicalTrials.gov) | August 2004 | 11/5/2007 | Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets | Effects of Growth Hormone Treatment on Body Proportions and Final Height Among Small Children With X-Linked Hypophosphatemic Rickets | Hypophosphatemic Rickets;Growth Disorders;Somatropin Therapy | Drug: somatropin | University of Rostock | NULL | Active, not recruiting | 3 Years | 10 Years | Both | Phase 1 | Germany |